The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Improved Solubility and Dissolution Rate of Ketoprofen by the Formation of Multicomponent Crystals with Tromethamine
Open accessAbstract
This study aims to improve the dissolution rate of ketoprofen by preparing multicomponent crystals with tromethamine. The multicomponent crystals (equimolar ratio) of ketoprofen and tromethamine were prepared by the solvent co-evaporation method. The solid-state properties of the resulting powder were characterized by powder X-ray diffraction, DSC thermal analysis, FT–IR spectroscopy, solubility, and in vitro dissolution rate. The crystal structure of the multicomponent crystal was determined by single-crystal X-ray diffraction analysis. The results showed that the powder X-ray diffraction pattern of the ketoprofen–tromethamine binary system was different from that of the starting materials. This difference indicates the formation of a new crystalline phase between ketoprofen and tromethamine (equimolar ratio). The DSC thermogram of the ketoprofen–tromethamine binary system exhibited a single and sharp endothermic peak at 128.67 °C, attributed to the melting point of a multicomponent crystal of ketoprofen–tromethamine. A single-crystal X-ray analysis revealed that ketoprofen–tromethamine formed a layered structure, salt-type multicomponent crystal. The solubility and dissolution rate of the multicomponent crystal were notably enhanced compared to the intact ketoprofen. The ketoprofen–tromethamine binary system forms salt-type multicomponent crystals, which can significantly increase the solubility and dissolution rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spackman, M. A., & Jayatilaka, D. (2009) · CrystEngComm · doi:10.1039/b818330a · Cited by 7,991
Serajuddin, A. T. M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980403l · Cited by 1,648
Salt formation to improve drug solubility
Serajuddin, A. T. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.010 · Cited by 1,425
Insoluble drug delivery strategies: review of recent advances and business prospects
Kalepu, S., & Nekkanti, V. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.07.003 · Cited by 1,410
Acid–base crystalline complexes and the pKa rule
Cruz-Cabeza, A. J. (2012) · CrystEngComm · doi:10.1039/c2ce26055g · Cited by 673
Bridging solubility between drug discovery and development
Di, L., Fish, P. V., & Mano, T. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.11.007 · Cited by 491
Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges
Cerreia Vioglio, P., Chierotti, M. R., & Gobetto, R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.001 · Cited by 350
Oral versus Topical NSAIDs in Rheumatic Diseases: A Comparison
Heyneman, C. A., Lawless-Liday, C., & Wall, G. C. (2000) · Drugs · doi:10.2165/00003495-200060030-00004 · Cited by 341
Overcoming poor oral bioavailability using nanoparticle formulations – opportunities and limitations
Desai, P. P., Date, A. A., & Patravale, V. B. (2012) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2011.12.001 · Cited by 199
Tsume, Y., Langguth, P., García‐Arieta, A., & Amidon, G. L. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1800 · Cited by 112
Metadata
- Authors
- Fitriani, L., Firdaus, W. A., Sidadang, W., Rosaini, H., Putra, O. D., Oyama, H., Uekusa, H., & Zaini, E.
- Venue
- Crystals
- Publisher
- MDPI AG
- Published
- 2022-02-17
- Volume
- 12
- Issue
- 2
- Pages
- 275
- ISSN
- 2073-4352 (ISSN-L)
- OpenAlex
- W4213117438
- Cited by
- 258
- References
- 20
- FWCI
- 17.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improved Solubility and Dissolution Rate of Ketoprofen by the Formation of Multicomponent Crystals with Tromethamine. https://app.cochat.ai/papers/10.3390/cryst12020275
- The paper
- Fitriani, L., Firdaus, W. A., Sidadang, W., Rosaini, H., Putra, O. D., Oyama, H., Uekusa, H., & Zaini, E. (2022). Improved Solubility and Dissolution Rate of Ketoprofen by the Formation of Multicomponent Crystals with Tromethamine. Crystals. https://doi.org/10.3390/cryst12020275
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
